Skip to main content

Table 1 Clinical characteristics of 40 CLL/SLL patients

From: Monoallelic and biallelic deletions of 13q14 in a group of CLL/SLL patients investigated by CGH Haematological Cancer and SNP array (8x60K)

Case No.

Sex

Age at diagnosis (y)

Diagnosis

Binet stage at enrollment

Time to treatment (mo)

Overall survival (mo)

CD38 > 30 % (1) CD38 ≤ 30 % (0)

1.

M

55

CLL

C

13

70+

1

2.

M

59

CLL

C

2

54

1

3.

M

73

CLL

C

18

43+

0

4.

M

58

SLL

C

1

27

1

5.

F

75

CLL

B

nd

73

1

6.

F

69

CLL

A

84

95+

0

7.

F

61

CLL

A

7

141+

1

8.

M

47

CLL

A

36

80+

0

9.

M

63

CLL

C

36

70+

1

10.

M

47

CLL

B

30

76+

0

11.

M

47

CLL

A

36

72+

0

12.

M

51

CLL

A

36+

36+

0

13.

M

34

CLL

A

20

139

0

14.

M

57

SLL

A

3

71+

1

15.

K

54

CLL

A

nt

138+

0

16.

M

67

CLL

C

1

17+

1

17.

M

24

CLL

C

64

148

1

18.

M

52

CLL

B

28

83

0

19.

F

63

SLL

A

76

96+

0

20.

M

64

CLL

C

4

42

1

21.

M

41

CLL

C

3

31+

1

22.

F

74

CLL

A

78

111

1

23.

F

63

CLL

B

53

62+

1

24.

M

78

CLL

C

7

32+

0

25.

M

64

CLL

C

0

66+

0

26.

F

51

CLL

A

nt

59+

0

27.

F

60

CLL

A

nt

175+

0

28.

F

66

CLL

A

nt

16+

0

29.

F

76

CLL

A

nt

8+

0

30.

M

76

CLL

C

30

48

1

31.

F

67

CLL

B

21

187+

0

32.

F

51

SLL

B

60

144+

0

33.

F

64

CLL

B

23

40+

1

34.

M

75

CLL

A

nt

39+

0

35.

F

64

CLL

B

89

107+

0

36.

M

76

CLL

C

0

5

0

37.

F

66

CLL

A

nt

59+

nd

38.

F

56

CLL

C

nt

131+

0

39.

M

53

CLL

C

1

8+

0

40.

F

60

CLL

C

0

39

nd

  1. y years, mo months, nd no data, nt not treated